Syntheses and Neuraminidase Inhibitory Activity of Multisubstituted Cyclopentane Amide Derivatives

Journal of Medicinal Chemistry

Volumn 47, Issue 8, 2004, Pages 1919-1929

  Chand, Pooran ^a   Babu, Y Sudhakar ^a   Bantia, Shanta ^a   Rowland, Scott ^a,b   Dehghani, Ali ^a,c   Kotian, Pravin L ^a   Hutchison, Tracy L ^a,d   Ali, Shoukath ^a,e   Brouillette, Wayne ^a,f   El Kattan, Yahya ^a   Lin, Tsu Hsing ^a  

^a BIOCRYST PHARMACEUTICALS INC   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c Nektar Therapeutics ^*  (United States)

^d NEKTAR THERAPEUTICS   (United States)

^e NeoPharm Inc   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CYCLOPENTANE DERIVATIVE; DIETHYLAMINE; SIALIDASE;

ANALYTIC METHOD; ARTICLE; CHIRALITY; DERIVATIZATION; DRUG SYNTHESIS; ENZYME ACTIVE SITE; EPITHELIUM CELL; INFLUENZA VIRUS; STEREOISOMERISM; VIRUS MUTANT; VIRUS PARTICLE; VISCOSITY;

ADMINISTRATION, INTRANASAL; AMIDES; ANIMALS; ANTIVIRAL AGENTS; CRYSTALLOGRAPHY, X-RAY; CYCLOPENTANES; INFLUENZA A VIRUS; MICE; MODELS, MOLECULAR; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 11144353776     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0303406     Document Type: Article

References (29)

1. Palese, P.; Tobita, K.; Ueda, M. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61, 397-410.
2. Liu, C.; Eichelberger, M. C.; Compans, R. W.; Air, G. M. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 1995, 69, 1099-1106.
3. Taylor, N. R.; von Itzstein, M. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J. Med. Chem. 1994, 37, 616-624.
4. von Itzstein, M.; Wu, W.-Y.; Jin, B. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydr. Res. 1994, 259, 301-305.
5. von Itzstein, M.; Wu, W.-Y.; Kok, G. B.; Pegg, M. S.; Dyason, J. C.; Phan, T. V.; Smythe, M. L.; White, H. F.; Oliver, S. W.; Colman, P. M.; Varghese, J. N.; Ryan, D. M.; Woods, J. M.; Bethell, R. C.; Hotham, V. J.; Cameron, J. M.; Penn, C. R. Rationeuraminidasel design of potent sialidase-based inhibitors of influenza virus replication. Neuraminidaseture 1993, 363, 418-423.
6. Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H. T.; Zhang, L. J.; Swamineuraminidasethan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C. Y.; Laver, W. G.; Stevens, R. C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural aneuraminidaselysis of carbocyclic sialic acid aneuraminidaselogues with potent anti-influenza activity. J. Am. Chem. Soc. 1997, 119, 681-690.
7. Babu, Y. S.; Chand, P.; Bantia, S.; Kotian, P.; Dehghani, A.; El-Kattan, Y.; Lin, T.-H.; Hutchison, T. L.; Elliott, A. J.; Parker, C. D.; Ananth, S. L.; Horn, L. L.; Laver, G. W.; Montgomery, J. A. BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J. Med. Chem. 2000, 43, 3482-3486.
8. Sorbera, A.; Castaner, J. RWJ-270201 (BCX-1812), anti-influenza neuraminidase (sialidase) inhibitor. Drugs Future 2000, 25 (3), 249-251.
9. Bantia, S.; Parker, C. D.; Ananth, S. L.; Horn, L. L.; Andries, K.; Chand, P.; Kotian, P. L.; Dehghani, A.; El-Kattan, Y.; Lin, T.; Hutchison, T. L.; Montgomery, J. A.; Kellogg, D. L.; Babu, Y. S. Comparison of the anti-influenza virus activity of RWJ-270201 with those of Oseltamivir and Zanamivir. Antimicrob. Agents Chemother. 2001, 45 (4), 1162-1167.
10. Sidwell, R. W.; Smee, D. F.; Huffman, J. H.; Barnard, D. L.; Bailey, K. W.; Morrey, J. D.; Babu, Y. S. In vivo influenza virus-inhibitory effects of the cyclopentene neuraminidase inhibitor RWJ-270201. Antimicrob. Agents Chemother. 2001, 45 (3), 749-757.
11. Chand, P.; Kotian, P. L.; Dehghani, A.; El-Kattan, Y.; Lin, T.-H.; Hutchison, T. L.; Babu, Y. S.; Bantia, S.; Elliott, A. J.; Montgomery, J. A. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity. J. Med. Chem. 2001, 44, 4379-4392.
12. Smith, P. W.; Sollis, S. L.; Howes, P. D.; Cherry, P. C.; Starkey, I. D. ; Cobley, K. N.; Weston, H.; Scicinski, J.; Merritt, A.; Whittington, A.; Wyatt, P.; Taylor, N.; Green, D.; Bethell, R.; Madar, S.; Fenton, R. J.; Morley, P. J.; Pateman, T.; Beresford, A. Dihydropyrancarboxamides related to zanamivir: A new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. J. Med. Chem. 1998, 41, 787-797.
13. Wyatt, P. C.; Coomber, B. A.; Evans, D. N.; Jack, T. I.; Fulton, H. E.; Wonacott, A. J. Sialidase inhibitors related to Zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides. Bioorg. Med. Chem. Lett. 2001, 11, 669-673.
14. Sollis, S. L.; Smith, P. W.; Howes, P. D.; Cherry, P. C.; Bethell, R. C. Novel inhibitors of influenza sialidase related to GG167. Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase. Bioorg. Med. Chem. Lett. 1996, 6, 1805-1808.
15. Kim, C. U.; Lew, W.; Williams, M. A.; Wu, H.; Zhang, L.; Chen, X.; Escarpe, P. A.; Laver, W. G.; Stevens, R. C.; Mendel, D. B. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. J. Med. Chem. 1998, 41, 2451-2460.
16. Zhang, L.; Williams, M. A.; Mendel, D. B.; Escarpe, P. A.; Chen, X.; Wang, K.-Y.; Graves, B. J.; Lawton, G.; Kim, C. U. Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 1751-1756.
17. Smith, P. W.; Robinson, J. E.; Evans, D. N.; Sollis, S. L.; Howes. P. D. ; Trivedi, N.; Bethell, R. C. Sialidase inhibitors related to Zanamivir: synthesis and biological evaluation of 4H-pyran 6-ether and ketone. Bioorg. Med. Chem. Lett. 1999, 9, 601-604.
18. Smith, P. W.; Trivedi, N.; Howes, P. D.; Sollis, S. L.; Rahim, G.; Bethell, R. C.; Lynn, S. Synthesis of a tetrasubstituted bicyclo-[2.2.2]octane as a potential inhibitor of influenza virus sialidase. Bioorg. Med. Chem. Lett. 1999, 9, 611-614.
19. 4-β-D-Glucopyranosiduronic Acids as Mimetics of 2,3-Unsaturated Sialic Acids for Sialidase Inhibition. Bioorg. Med. Chem. Lett. 1999, 9, 2065-2068.
20. Smith, P. W.; Whittington, A. R.; Sollis, S. L.; Howes, P. D.; Taylor, N. R. Novel inhibitors of influenza sialidases related to Zanamivir. Heterocyclic replacements of the glycerol sidechain. Bioorg. Med. Chem. Lett. 1997, 7, 2239-2242.
21. Stoll, V.; Stewart, K. D.; Maring, C. J.; Muchmore, S.; Giranda, V.; Gu, Y.-g. Y.; Wang, G.; Chen, Y.; Sun, M.; Zhao, C.; Kennedy, A. L.; Madigan, D. L. ; Xu, Y.; Saldivar, A.; Kati, W.; Laver, G.; Sowin, T.; Sham, H. L.; Greer, J.; Kempf, D. Influenza neuraminidase inhibitors: Structure-based design of a novel inhibitor series. Biochemistry 2003, 42, 718-727.
22. Wang, G.; Chen, Y.; Wang, S.; Gentles, R.; Sowin, T.; Kati, W.; Muchmore, S.; Giranda, V.; Stewart, K.; Sham, H.; Kempf, D.; Laver, W. G. Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. J. Med. Chem. 2001, 44, 1192-1201.
23. Kati, W. M.; Montgomery, D.; Maring, C.; Stoll, V. S.; Giranda, V.; Chen, X.; Laver, W. G.; Kohlbrenner, W.; Norbeck, D. W. Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase. Antimicrob. Agents Chemother. 2001, 45, 2563-2570.
24. Kati, W. M.; Montgomery, D.; Carrick, R.; Gubareva, L.; Maring, C.; McDaniel, K.; Steffy, K.; Molla, A.; Hayden, F.; Kempf, D.; Kohlbrenner, W. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Antimicrob. Agents Chemother. 2002, 46, 1014-1021.
25. Carey, F. A.; Court, A. S. Silicon-containing carbanions. II. Ketene thioacetal synthesis 2-lithio-2-trimethylsilyl-1,3-dithiane. J. Org. Chem. 1972, 37, 1926-1929.
26. Kolb, M. Ketene dithioacetals in organic synthesis: recent developments. Synthesis 1990, 171-190.
27. Jones, P. F.; Lappert, M. F.; Szary, A. C. Wittig-type reactions of 2-lithio-2-trimethylsilyl-1,3-dithian and related reactions. J.C.S. Perkin 1 1973, 2272-2277.
28. Johansson, B. E.; Grajower, B.; Kilbourne, E. D. Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine 1993, 11, 1037-1039.
29. Potier, M.; Mameli, L.; Belisle, M.; Dallaire, L.; Melancon, S. B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α -D-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94, 287-296.